Mitchell E Horwitz

Mitchell E Horwitz

UNVERIFIED PROFILE

Are you Mitchell E Horwitz?   Register this Author

Register author
Mitchell E Horwitz

Mitchell E Horwitz

Publications by authors named "Mitchell E Horwitz"

Are you Mitchell E Horwitz?   Register this Author

47Publications

1203Reads

9Profile Views

Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy.

Biol Blood Marrow Transplant 2019 Nov 9. Epub 2019 Nov 9.

Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.11.005DOI Listing
November 2019

Intestinal Acute Graft-versus-Host Disease: A Bug Highway to the Bloodstream.

Biol Blood Marrow Transplant 2019 Aug 19;25(8):e250-e251. Epub 2019 Jun 19.

Duke University School of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.011DOI Listing
August 2019

Current and future perspectives on allogeneic transplantation using ex vivo expansion or manipulation of umbilical cord blood cells.

Int J Hematol 2019 Jul 23;110(1):50-58. Epub 2019 May 23.

Adult Blood and Marrow Transplant Program, Duke University School of Medicine, 2400 Pratt St. DUMC 3961, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02670-6DOI Listing
July 2019

HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature.

Case Rep Transplant 2018 12;2018:2376483. Epub 2018 Mar 12.

Adult Blood and Marrow Transplant Program, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/2376483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867646PMC
March 2018

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8177DOI Listing
December 2017

Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.

Biol Blood Marrow Transplant 2017 Aug 11;23(8):1290-1294. Epub 2017 Apr 11.

Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.04.007DOI Listing
August 2017

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

J Clin Oncol 2017 Apr 13;35(11):1154-1161. Epub 2017 Feb 13.

Bart L. Scott and H. Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcelo C. Pasquini, Brent R. Logan, Mehdi Hamadani, and Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; Juan Wu and Adam M. Mendizabal, Emmes Corporation, Rockville, MD; Steven M. Devine, Ohio State University Comprehensive Cancer Center, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Erica D. Warlick, University of Minnesota, Minneapolis; Jennifer Le-Rademacher, Mayo Clinic, Rochester, MN; Hugo F. Fernandez, Moffitt Cancer Center, Tampa, FL; Edwin P. Alyea, Dana Farber Cancer Institute, Boston, MA; Asad Bashey, Northside Hospital Cancer Institute, Atlanta, GA; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Nancy L. Geller and Eric Leifer, National Heart, Lung, and Blood Institute, Bethesda, MD; and Mitchell E. Horwitz, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455603PMC
April 2017

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity.

Adv Radiat Oncol 2016 Oct-Dec;1(4):272-280. Epub 2016 Jul 15.

Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.adro.2016.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514157PMC
July 2016

Ex Vivo Expansion or Manipulation of Stem Cells to Improve Outcome of Umbilical Cord Blood Transplantation.

Curr Hematol Malig Rep 2016 Feb;11(1):12-8

Adult Blood and Marrow Transplant Program, Duke University School of Medicine, 2400 Pratt St. DUMC 3961, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-015-0297-7DOI Listing
February 2016

Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation.

Cytotherapy 2015 Jun 14;17(6):730-738. Epub 2015 Mar 14.

Department of Hemato-Oncology and Center for Stem Cell and Cell Therapy, Istituto G. Gaslini Children's Hospital Scientific Institute, Genova, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14653249150006
Publisher Site
http://dx.doi.org/10.1016/j.jcyt.2015.02.004DOI Listing
June 2015

Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.

Biol Blood Marrow Transplant 2014 Feb 20;20(2):257-63. Epub 2013 Nov 20.

Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140655PMC
February 2014

Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.

Int J Radiat Oncol Biol Phys 2011 Nov 6;81(3):812-8. Epub 2010 Oct 6.

Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016100094
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2010.06.058DOI Listing
November 2011

Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Biol Blood Marrow Transplant 2011 Jun 22;17(6):867-74. Epub 2010 Sep 22.

Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877679PMC
June 2011

Non-myeloablative umbilical cord blood transplantation.

Best Pract Res Clin Haematol 2010 Jun;23(2):231-6

Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2010.06.001DOI Listing
June 2010

Sources of human and murine hematopoietic stem cells.

Curr Protoc Immunol 2007 Nov;Chapter 22:Unit 22A.2

Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/0471142735.im22a02s79DOI Listing
November 2007

Chronic graft-versus-host disease.

Blood Rev 2006 Jan 7;20(1):15-27. Epub 2005 Apr 7.

Division of Cellular Therapy, Duke University Medical Center, 2400 Pratt Street DUMC 3961, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2005.01.007DOI Listing
January 2006

Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens.

Transfusion 2004 Feb;44(2):229-38

Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Insitutes of Health, Bethesda, Maryland 20892-1184, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2004.00668.xDOI Listing
February 2004

Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency.

Blood 2003 Oct 12;102(7):2692-4. Epub 2003 Jun 12.

National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-04-1268DOI Listing
October 2003

Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.

Blood 2003 Oct 26;102(8):2789-97. Epub 2003 Jun 26.

Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg 10, Rm 11N112, 10 Center Dr, MSC 1886, Bethesda, MD 20892-1886, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-05-1482DOI Listing
October 2003

Immunomodulation in stem-cell transplantation.

Curr Opin Pharmacol 2002 Aug;2(4):452-7

Bone Marrow Transplant, National Institutes of Health, Pharmacy Department Building 10, Room 1N-257, Bethesda, Maryland 20892-1196, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1471-4892(02)00174-1DOI Listing
August 2002